TY - JOUR T1 - Axillary Dissection <em>vs</em>. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution Experience JF - In Vivo JO - In Vivo SP - 1941 LP - 1947 DO - 10.21873/invivo.11689 VL - 33 IS - 6 AU - RICCARDO ARISIO AU - FULVIO BORELLA AU - MAURO PORPIGLIA AU - ANTONIO DURANDO AU - ROBERTO BELLINO AU - MARIA GRAZIA BAU AU - CORRADO DE SANCTIS AU - SAVERIO DANESE AU - CHIARA BENEDETTO AU - DIONYSSIOS KATSAROS Y1 - 2019/11/01 UR - http://iv.iiarjournals.org/content/33/6/1941.abstract N2 - Background/Aim: Axillary surgery of breast cancer patients is undergoing a paradigm shift, as axillary lymph node dissection's (ALND) usefulness is being questioned in the treatment of patients with tumor-positive sentinel lymph node biopsy (SLNB). The aim of this study was to investigate the overall survival (OS) and relapse-free survival (RFS) of patients with positive SLNB treated with ALND or not. Patients and Methods: We investigated 617 consecutive patients with cN0 operable breast cancer with positive SLNB undergoing mastectomy or conservative surgery. A total of 406 patients underwent ALND and 211 were managed expectantly. Results: No significant difference in OS and RFS was found between the two groups. The incidence of loco-regional recurrence in the SLNB-only group and the ALND group was low and not significant. Conclusion: The type of breast cancer surgery and the omission of ALND does not improve OS or RSF rate in cases with metastatic SLN. ER -